General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chavez–Tapia NC et al. – Rimonabant is associated with an increased risk of adverse events. Despite of an increasing interest for its use on fatty liver, the security profile and efficacy it is needs to be carefully assessed before its recommendation. At present the use of rimonabant on fatty liver cannot be recommended.

Related Articles

Adrenal Cortisol Secretion Capacity in Children and Adolescents with New-Onset, Mild Crohn's Disease
The Journal of Pediatrics, 10/30/09    Relevance Score: 84%

Cross-Sectional Analysis of Health-Related Quality of Life in Pediatric Liver Transplant Recipients
The Journal of Pediatrics, 10/30/09    Relevance Score: 84%

Improved Adherence and Outcomes for Pediatric Liver Transplant Recipients by Using Text Messaging
Pediatrics, 10/28/09    Relevance Score: 84%

Salix Pharmaceuticals Previews American College Of Gastroenterology 2009 Annual Scientific Meeting
Salix Pharmaceuticals, 10/27/09    Relevance Score: 84%

Long-term Clinical Significance of Thyroid Autoimmunity in Children with Celiac Disease
The Journal of Pediatrics, 10/23/09    Relevance Score: 84%

Today in Hepatology...keeping you current

Hyperuricemia, Gout, and Renal Function After Liver Transplantation
Transplantation, 12/18/09

No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09

Air cavitogram as investigative modality for Amoebic Liver Abscess
The Internet Journal of Gastroenterology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address